- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有749家主力机构披露2025-12-31报告期持股数据，持仓量总计2.68亿股，占流通A股47.28%
- 波段诊断：
-
技术面诊股
诊断结果：8.0技术面打败了94%的股票
技术面评分前10的股票
近期的平均成本为58.53元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为58.53元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"58.53","date":1776240205,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，明显跑赢行业平均水平。
[{"date":"2026.04.16","stock":"-0.73","trade":"-0.04","ind":"2.05"},{"date":"2026.04.15","stock":"-0.67","trade":"0.14","ind":"-0.97"},{"date":"2026.04.14","stock":"6.05","trade":"1.73","ind":"1.61"},{"date":"2026.04.13","stock":"-3.11","trade":"-1.22","ind":"0.69"},{"date":"2026.04.10","stock":"3.69","trade":"0.70","ind":"2.24"},{"date":"2026.04.09","stock":"-0.43","trade":"-1.86","ind":"-0.33"},{"date":"2026.04.08","stock":"1.10","trade":"2.51","ind":"4.79"},{"date":"2026.04.07","stock":"0.24","trade":"0.66","ind":"0.36"},{"date":"2026.04.03","stock":"-1.78","trade":"-3.06","ind":"-0.99"},{"date":"2026.04.02","stock":"-1.31","trade":"-0.64","ind":"-1.60"},{"date":"2026.04.01","stock":"5.98","trade":"5.25","ind":"1.70"},{"date":"2026.03.31","stock":"2.18","trade":"0.22","ind":"-1.81"},{"date":"2026.03.30","stock":"-1.44","trade":"1.19","ind":"-0.25"},{"date":"2026.03.27","stock":"5.26","trade":"4.12","ind":"1.13"},{"date":"2026.03.26","stock":"0.59","trade":"-0.95","ind":"-1.41"},{"date":"2026.03.25","stock":"3.44","trade":"1.63","ind":"1.95"},{"date":"2026.03.24","stock":"2.65","trade":"4.75","ind":"1.43"},{"date":"2026.03.23","stock":"-5.32","trade":"-5.76","ind":"-3.76"},{"date":"2026.03.20","stock":"-1.88","trade":"-2.55","ind":"-0.25"},{"date":"2026.03.19","stock":"-3.43","trade":"-3.01","ind":"-2.02"},{"date":"2026.03.18","stock":"0.08","trade":"0.92","ind":"1.05"}]
泰格医药,深证成指,医疗服务指数
压力支撑
该股压力位为58.37元，支撑位为57.64元。
[{"text":"\u538b\u529b\u4f4d","value":"58.37","date":1776268800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"57.64","date":1776268800,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.3资金面打败了47%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：04月16日 20:30
| 机构今日流向(万元) | 573.77 | 机构5日流向(万元) | -1677.82 |
| 机构10日流向(万元) | -4710.13 | 机构20日流向(万元) | -5833.67 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量增加575.64万股，其中基金净减仓146家，主力净增仓91家，请投资者中长期谨慎为宜。
截止2025-12-31，共749家主力机构（基金747家，一般法人1家，社保基金1家），持仓量总计26772.46万股，占流通A股47.28%
其中，基金持仓与2025-06-30相比：
增仓：121家 ，增持 2548.65万股
减仓：267家 ，减持 4399.98万股
新出现在主力名单中：323家 ，持有3254.57万股
从主力名单中消失：232家 ，原持有3916.35万股
其中，基金持仓与2025-06-30相比：
增仓：121家 ，增持 2548.65万股
减仓：267家 ，减持 4399.98万股
新出现在主力名单中：323家 ，持有3254.57万股
从主力名单中消失：232家 ，原持有3916.35万股
消息面诊股
诊断结果：6.8消息面打败了76%的股票
今日有利好新闻的公司
近期该股利好消息较多，投资者可加强关注。
更多>>个股资讯
- 中金：国家优化创新药新药上市首发价格机制 药品行业
2026-04-16 - 浙商证券：定价权回归市场与多元支付手段共振 创新药
2026-04-16 - 泰格医药：4月15日持仓该股ETF资金净流出57.
2026-04-16 - 泰格医药：4月15日获融资买入1.10亿元
2026-04-16 - 结构性分化复苏趋势明显，触底反弹的内需成头部CXO
2026-04-15 - 三生制药与泰格医药达成全面战略合作 共筑创新药研发
2026-04-15 - 生物医药投融资回暖，CXO行业迎来新机遇
2026-04-15 - 泰格医药：公司具备全球同步研发服务能力的国际性CR
2026-04-15 - 泰格医药：公司专注提供临床试验全过程专业服务
2026-04-15 - 泰格医药：公司制定了《控股子公司重大事项报告制度》
2026-04-15
消息列表
| 利好 | 分红转增 | 10派1.26元(含税) | 2026-03-31 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-31 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-02-10 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2026-01-29 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-29 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-29 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-15 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 1条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.0行业面打败了73%的股票
医疗服务行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.04.16","price":"2.05","value":"-0.04"},{"date":"2026.04.15","price":"-0.97","value":"0.14"},{"date":"2026.04.14","price":"1.61","value":"1.73"},{"date":"2026.04.13","price":"0.69","value":"-1.22"},{"date":"2026.04.10","price":"2.24","value":"0.70"},{"date":"2026.04.09","price":"-0.33","value":"-1.86"},{"date":"2026.04.08","price":"4.79","value":"2.51"},{"date":"2026.04.07","price":"0.36","value":"0.66"},{"date":"2026.04.03","price":"-0.99","value":"-3.06"},{"date":"2026.04.02","price":"-1.60","value":"-0.64"},{"date":"2026.04.01","price":"1.70","value":"5.25"},{"date":"2026.03.31","price":"-1.81","value":"0.22"},{"date":"2026.03.30","price":"-0.25","value":"1.19"},{"date":"2026.03.27","price":"1.13","value":"4.12"},{"date":"2026.03.26","price":"-1.41","value":"-0.95"},{"date":"2026.03.25","price":"1.95","value":"1.63"},{"date":"2026.03.24","price":"1.43","value":"4.75"},{"date":"2026.03.23","price":"-3.76","value":"-5.76"},{"date":"2026.03.20","price":"-0.25","value":"-2.55"},{"date":"2026.03.19","price":"-2.02","value":"-3.01"},{"date":"2026.03.18","price":"1.05","value":"0.92"}]
深证成指,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 昭衍新药 | 31.59% | 4.14% | 6.0分 |
| 2 | 药康生物 | 22.62% | 9.96% | 6.6分 |
| 3 | 美迪西 | 22.34% | 9.51% | 6.9分 |
| 4 | 金凯生科 | 21.65% | 13.23% | 6.7分 |
| 5 | 百奥赛图 | 21.38% | -2.35% | 6.8分 |
| 6 | 益诺思 | 21.34% | 2.50% | 5.8分 |
| 8 | 奥浦迈 | 17.48% | 15.07% | 6.5分 |
| 10 | 康龙化成 | 13.40% | 2.75% | 5.8分 |
| 12 | 睿智医药 | 11.63% | 1.24% | 5.1分 |
| 14 | 皓元医药 | 10.77% | 5.03% | 5.8分 |
| 16 | 毕得医药 | 9.30% | 5.60% | 6.1分 |
| 18 | 成都先导 | 7.11% | 2.39% | 5.5分 |
| 20 | 普蕊斯 | 6.54% | -0.22% | 5.8分 |
| 22 | 万邦医药 | 4.77% | 5.16% | 4.6分 |
| 24 | 华康洁净 | 4.22% | 2.95% | 5.2分 |
| 26 | 药石科技 | 2.55% | 3.07% | 4.4分 |
| 28 | 诚达药业 | 0.75% | -18.87% | 4.4分 |
| 30 | 南模生物 | 0.57% | 0.27% | 5.7分 |
| 32 | 金域医学 | -1.51% | 4.69% | 5.6分 |
| 34 | *ST生物 | -1.79% | -1.20% | 5.0分 |
| 36 | 盈康生命 | -2.61% | -0.32% | 5.2分 |
| 38 | 大湖股份 | -3.33% | -8.45% | 5.0分 |
| 40 | ST中珠 | -3.67% | 0.00% | 4.7分 |
| 42 | 和元生物 | -5.41% | 1.27% | 4.9分 |
| 44 | 爱尔眼科 | -6.17% | 0.84% | 4.8分 |
| 46 | 澳洋健康 | -7.64% | -1.28% | 5.6分 |
| 48 | 何氏眼科 | -8.46% | 1.14% | 5.6分 |
| 50 | 贝瑞基因 | -9.47% | -0.29% | 5.0分 |
| 52 | 美年健康 | -11.40% | -0.56% | 5.1分 |
| 54 | 皓宸医疗 | -11.93% | -3.09% | 4.2分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 16/102 ， 35/102。
[{"date":"2025-09-30","value":"4.88","vol":"3.27"},{"date":"2025-06-30","value":"1.86","vol":"2.25"},{"date":"2025-03-31","value":"0.80","vol":"0.89"},{"date":"2024-12-31","value":"1.94","vol":"-0.23"},{"date":"2024-09-30","value":"3.87","vol":"3.03"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.88 | 1.86 | 0.80 | 1.94 | 3.87 |
| 行业(%) | 3.27 | 2.25 | 0.89 | -0.23 | 3.03 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"29.16","vol":"36.42"},{"date":"2025-06-30","value":"30.09","vol":"36.57"},{"date":"2025-03-31","value":"30.03","vol":"34.64"},{"date":"2024-12-31","value":"33.95","vol":"35.34"},{"date":"2024-09-30","value":"38.88","vol":"36.52"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
29.16 | 30.09 | 30.03 | 33.95 | 38.88 |
| 行业(%) | 36.42 | 36.57 | 34.64 | 35.34 | 36.52 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 32/102 ， 25/102。
[{"date":"2025-09-30","value":"-0.82","vol":"3.19"},{"date":"2025-06-30","value":"-3.21","vol":"3.02"},{"date":"2025-03-31","value":"-5.79","vol":"-0.59"},{"date":"2024-12-31","value":"-10.58","vol":"-0.26"},{"date":"2024-09-30","value":"-10.32","vol":"0.50"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-0.82 | -3.21 | -5.79 | -10.58 | -10.32 |
| 行业(%) | 3.19 | 3.02 | -0.59 | -0.26 | 0.50 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"25.45","vol":"21.04"},{"date":"2025-06-30","value":"-22.22","vol":"-63.64"},{"date":"2025-03-31","value":"-29.61","vol":"-24.37"},{"date":"2024-12-31","value":"-79.99","vol":"-106.02"},{"date":"2024-09-30","value":"-56.72","vol":"-177.29"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
25.45 | -22.22 | -29.61 | -79.99 | -56.72 |
| 行业(%) | 21.04 | -63.64 | -24.37 | -106.02 | -177.29 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 45/102 ， 2/102。
[{"date":"2025-09-30","value":"0.17","vol":"0.31"},{"date":"2025-06-30","value":"0.11","vol":"0.21"},{"date":"2025-03-31","value":"0.05","vol":"0.10"},{"date":"2024-12-31","value":"0.23","vol":"0.42"},{"date":"2024-09-30","value":"0.17","vol":"0.30"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.17 | 0.11 | 0.05 | 0.23 | 0.17 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.42 | 0.30 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"93.82","vol":"11.00"},{"date":"2025-06-30","value":"60.13","vol":"7.17"},{"date":"2025-03-31","value":"31.99","vol":"3.69"},{"date":"2024-12-31","value":"157.57","vol":"15.82"},{"date":"2024-09-30","value":"135.87","vol":"13.91"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
93.82 | 60.13 | 31.99 | 157.57 | 135.87 |
| 行业(次) | 11.00 | 7.17 | 3.69 | 15.82 | 13.91 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"18.64","vol":"16.58"},{"date":"2025-06-30","value":"12.49","vol":"15.86"},{"date":"2025-03-31","value":"12.65","vol":"-1.13"},{"date":"2024-12-31","value":"33.75","vol":"22.25"},{"date":"2024-09-30","value":"23.48","vol":"13.29"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 18.64 | 12.49 | 12.65 | 33.75 | 23.48 |
| 行业 | 16.58 | 15.86 | -1.13 | 22.25 | 13.29 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.55","vol":"0.91"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.98","vol":"1.27"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.55 | - | 0.98 | - |
| 行业 | 0.01 | 0.91 | 0.00 | 1.27 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 7/102 ， 28/102。
[{"date":"2025-09-30","value":"2.16","vol":"3.73"},{"date":"2025-06-30","value":"1.83","vol":"3.63"},{"date":"2025-03-31","value":"1.62","vol":"3.81"},{"date":"2024-12-31","value":"1.72","vol":"3.63"},{"date":"2024-09-30","value":"1.37","vol":"4.03"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.16 | 1.83 | 1.62 | 1.72 | 1.37 |
| 行业 | 3.73 | 3.63 | 3.81 | 3.63 | 4.03 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.08","vol":"2.99"},{"date":"2025-06-30","value":"1.76","vol":"2.91"},{"date":"2025-03-31","value":"1.56","vol":"3.08"},{"date":"2024-12-31","value":"1.66","vol":"2.94"},{"date":"2024-09-30","value":"1.32","vol":"3.30"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.08 | 1.76 | 1.56 | 1.66 | 1.32 |
| 行业 | 2.99 | 2.91 | 3.08 | 2.94 | 3.30 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 45/102 ， 44/102。
[{"date":"2025-09-30","value":"14.16","vol":"32.51"},{"date":"2025-06-30","value":"15.93","vol":"33.52"},{"date":"2025-03-31","value":"16.78","vol":"32.55"},{"date":"2024-12-31","value":"16.07","vol":"33.22"},{"date":"2024-09-30","value":"19.35","vol":"30.79"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
14.16 | 15.93 | 16.78 | 16.07 | 19.35 |
| 行业(%) | 32.51 | 33.52 | 32.55 | 33.22 | 30.79 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.19","vol":"0.93"},{"date":"2025-06-30","value":"0.22","vol":"0.96"},{"date":"2025-03-31","value":"0.23","vol":"0.98"},{"date":"2024-12-31","value":"0.22","vol":"1.03"},{"date":"2024-09-30","value":"0.28","vol":"0.85"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.19 | 0.22 | 0.23 | 0.22 | 0.28 |
| 行业(%) | 0.93 | 0.96 | 0.98 | 1.03 | 0.85 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 西部证券 | 2026-04-14 | 买入 | |
| 中泰证券 | 2026-04-13 | 买入 | 买入 |
| 国泰海通证券 | 2026-04-12 | 买入 | |
| 中信建投证券 | 2026-04-08 | 买入 | 买入 |
| 东北证券 | 2026-04-07 | 增持 | |
| 财信证券 | 2026-04-07 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"20.07","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"20.25","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"4.05","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"8.88","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"11.77","blueLineValue":"1.37","type":"YC"}]